Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Cancer Treatment and Research|January 1, 2019
NK-Cell LymphomasDai Chihara, Yasuhiro Oki
Expert Opinion on Biological Therapy|September 10, 2014
Brentuximab vedotin for treatment of systemic T-cell lymphomaDai Chihara, Yasuhiro Oki
Current Hematologic Malignancy Reports|January 29, 2018
Central Nervous System Involvement in Peripheral T Cell LymphomaDai Chihara, Yasuhiro Oki
International Journal of Hematology|April 23, 2011
High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphomaDai Chihara, Yasuhiro Oki, Hiroshi Onoda, et al.
Leukemia & Lymphoma|July 13, 2011
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression modelDai Chihara, Yasuhiro Oki, Keitaro Matsuo, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2011
Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphomaHarumi Kato, Kazuhito Yamamoto, Hirofumi Taji, et al.
European Journal of Haematology|February 13, 2010
Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scanDai Chihara, Yasuhiro Oki, Shouji Ine, et al.
Hematological Oncology|September 14, 2018
Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotinDai Chihara, Shannon Wong, Tatyana Feldman, et al.
Leukemia & Lymphoma|October 29, 2009
Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathyDai Chihara, Yasuhiro Oki, Shouji Ine, et al.
Annals of Hematology|January 9, 2019
Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?Dai Chihara, Yasuhiro Oki, Michelle A Fanale, et al.
Pageof 24